Mitochondrial Metabolism in Breast Cancer
Frontiers in Bioscience-Landmark · 16.03.2026 · 31 (3)
DOI: 10.31083/fbl45543 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 16.03.2026. Verfasst von Qian Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy and Pharmacology, University of South China, 421001 Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Mitochondria, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC)-General Program, Shenzhen Science and Technology Innovation Commission-Basic Research (General Program), National Natural Science Foundation of China (NSFC)—General Program.
Abstract (Originalsprache)
Breast cancer is the most prevalent malignant tumor among women worldwide. Its progression is driven, in part, by mitochondrial metabolic dysregulation, which can also contribute to therapeutic resistance. Although targeting mitochondrial metabolism offers new opportunities for treatment, significant therapeutic challenges remain. These include metabolic heterogeneity among subtypes and individual patients, drug resistance arising from metabolic plasticity, and suboptimal clinical translation of metabolic therapies. This review systematically synthesizes the mitochondrial metabolic mechanisms underlying different breast cancer subtypes, emphasizing the spatial network regulatory functions of mitochondrial metabolism. It further critically evaluates combined therapeutic strategies targeting metabolic vulnerabilities. By integrating current research limitations with emerging breakthroughs, we outline novel therapeutic frameworks to advance the development of precision medicine approaches focused on mitochondrial metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy and Pharmacology, University of South China, 421001 Hengyang, Hunan, China.
- Laboratory Medicine Center, Shenzhen Luohu Hospital Group, The Third Affiliated Hospital (The Affiliated Luohu Hospital) of Shenzhen University, Shenzhen University, 518001 Shenzhen, Guangdong, China.
- School of Medicine, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China.
- Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, The F…
Förderung
- National Natural Science Foundation of China (NSFC)-General Program
- Shenzhen Science and Technology Innovation Commission-Basic Research (General Program)
- National Natural Science Foundation of China (NSFC)—General Program
- Shenzhen Science and Technology Innovation Commission—Basic Research
Zitieren
APA
Hu, Q., Luo, Z., Yuan, W., Zou, Q., Wang, L., He, Y., Shen, Y., Wen, X., Chen, S., Liu, Q., Luo, D., & Guo, Z. (2026). Mitochondrial Metabolism in Breast Cancer. Frontiers in Bioscience-Landmark, 31(3). https://doi.org/10.31083/fbl45543
Vancouver
Hu Q, Luo Z, Yuan W, Zou Q, Wang L, He Y, et al. Mitochondrial Metabolism in Breast Cancer. Frontiers in Bioscience-Landmark. 2026;31(3). doi:10.31083/fbl45543
BibTeX
@article{Hu2026,
author = {Hu, Qian and Luo, Zhihao and Yuan, Weixi and Zou, Qingshuang and Wang, Li and He, Yan and Shen, Yao and Wen, Xiaosha and Chen, Shang and Liu, Quan and Luo, Dixian and Guo, Zifen},
title = {Mitochondrial Metabolism in Breast Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {3},
doi = {10.31083/fbl45543}
}
EUVIMED